Bayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trials. [electronic resource]
- Journal of biopharmaceutical statistics 2014
- 310-25 p. digital
Publication Type: Journal Article
1520-5711
10.1080/10543406.2013.863779 doi
Algorithms Antineoplastic Agents--therapeutic use Bayes Theorem Clinical Trials, Phase I as Topic--methods Humans Neoplasms--drug therapy Treatment Outcome